David K. Yang

David K. Yang is a professional with extensive experience in investment and operational strategy within the life sciences sector. Currently part of the investment team at Lux Capital since 2024, Yang co-founded Latus Bio and led operations and strategy from 2022 to 2024. Prior to that, involvement with 8VC included focusing on early-stage life sciences investments from 2020 to 2024, contributing to various portfolio companies as a board observer. Yang has a strong research background, having served as a research associate at the Broad Institute of MIT and Harvard, specializing in RNA targeting CRISPR systems for viral diagnostics. Educational credentials include an A.B. from Harvard University in a joint concentration of Computer Science and Chemical & Physical Biology. Yang is also recognized for starting the Bio-IT Fellowship.